CoV-Sym:开发一种经心理测量学验证的COVID-19患者报告结果测量方法

C. Lythgoe, A. Rowe, O. Aiyegbusi, L. Chambers, F. Sherratt, J. Wood, B. Young, D. Wootton
{"title":"CoV-Sym:开发一种经心理测量学验证的COVID-19患者报告结果测量方法","authors":"C. Lythgoe, A. Rowe, O. Aiyegbusi, L. Chambers, F. Sherratt, J. Wood, B. Young, D. Wootton","doi":"10.1183/13993003.congress-2022.3312","DOIUrl":null,"url":null,"abstract":"Background: Patient reported outcome measures (PROMs) provide a standardised method to capture patient perspectives which can be used in comparative effectiveness research to inform the evaluation of treatment. Thus far, PROMs have focussed on the long-term sequelae of COVID-19 rather than the acute illness and initial recovery period. Aim(s): To design a psychometrically validated COVID-19 specific PROM to be used in the acute and recovery phase of illness. Method(s): A review of existing literature, evaluation of existing PROMs, input from local experts (n=15) and in-depth qualitative concept elicitation interviews with patients (n=8) were used to create a conceptual framework which informed the generation of items included in the PROM. Cognitive interviews with patients (n=8) were then used to develop and refine the items for inclusion in the PROM and confirm the content and face validity of the draft tool. A nominal group meeting of the expert panel (n=6) was held to confirm the final items for inclusion. Result(s): The CoV-Sym PROM consists of 19 domains and 44 items which are scored using a five-point Likert scale to enable objective measurement of patients' symptomatic recovery from acute COVID-19 illness. Questions address physical, psychological and social domains. Cognitive interviews revealed acceptable content and face validity. Conclusion(s): With the involvement of both patients and experts in the development and validation process, we have created the first COVID-19 specific PROM to measure patient's symptomatic recovery from acute COVID-19 infection. It is ready for further psychometric testing to confirm reliability and responsiveness, the results of which will be presented.","PeriodicalId":420846,"journal":{"name":"10.01 - Respiratory infections and bronchiectasis","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CoV-Sym: The development of a psychometrically validated patient reported outcome measure for COVID-19\",\"authors\":\"C. Lythgoe, A. Rowe, O. Aiyegbusi, L. Chambers, F. Sherratt, J. Wood, B. Young, D. Wootton\",\"doi\":\"10.1183/13993003.congress-2022.3312\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Patient reported outcome measures (PROMs) provide a standardised method to capture patient perspectives which can be used in comparative effectiveness research to inform the evaluation of treatment. Thus far, PROMs have focussed on the long-term sequelae of COVID-19 rather than the acute illness and initial recovery period. Aim(s): To design a psychometrically validated COVID-19 specific PROM to be used in the acute and recovery phase of illness. Method(s): A review of existing literature, evaluation of existing PROMs, input from local experts (n=15) and in-depth qualitative concept elicitation interviews with patients (n=8) were used to create a conceptual framework which informed the generation of items included in the PROM. Cognitive interviews with patients (n=8) were then used to develop and refine the items for inclusion in the PROM and confirm the content and face validity of the draft tool. A nominal group meeting of the expert panel (n=6) was held to confirm the final items for inclusion. Result(s): The CoV-Sym PROM consists of 19 domains and 44 items which are scored using a five-point Likert scale to enable objective measurement of patients' symptomatic recovery from acute COVID-19 illness. Questions address physical, psychological and social domains. Cognitive interviews revealed acceptable content and face validity. Conclusion(s): With the involvement of both patients and experts in the development and validation process, we have created the first COVID-19 specific PROM to measure patient's symptomatic recovery from acute COVID-19 infection. It is ready for further psychometric testing to confirm reliability and responsiveness, the results of which will be presented.\",\"PeriodicalId\":420846,\"journal\":{\"name\":\"10.01 - Respiratory infections and bronchiectasis\",\"volume\":\"29 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"10.01 - Respiratory infections and bronchiectasis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2022.3312\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"10.01 - Respiratory infections and bronchiectasis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2022.3312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:患者报告的结果测量(PROMs)提供了一种标准化的方法来捕捉患者的观点,可用于比较有效性研究,以告知治疗评估。到目前为止,prom关注的是COVID-19的长期后遗症,而不是急性疾病和初始恢复期。目的:设计一种心理测量学验证的COVID-19特异性PROM,用于疾病的急性期和恢复期。方法:通过对现有文献的回顾、对现有PROM的评估、当地专家的意见(n=15)和对患者进行深入的定性概念启发访谈(n=8),建立了一个概念框架,该框架为PROM中包含的项目的生成提供了信息。然后使用与患者的认知访谈(n=8)来开发和完善纳入PROM的项目,并确认草稿工具的内容和面效度。举行了一次专家小组名义上的小组会议(n=6),以确认列入的最后项目。结果:CoV-Sym PROM由19个域和44个项目组成,采用五点李克特量表进行评分,以客观衡量患者急性COVID-19疾病的症状恢复情况。问题涉及身体,心理和社会领域。认知访谈揭示了可接受的内容和面孔效度。结论:在患者和专家共同参与的开发和验证过程中,我们创建了第一个COVID-19特异性PROM,用于测量患者急性COVID-19感染后的症状恢复。它已准备好进行进一步的心理测量测试,以确认可靠性和反应性,其结果将被呈现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CoV-Sym: The development of a psychometrically validated patient reported outcome measure for COVID-19
Background: Patient reported outcome measures (PROMs) provide a standardised method to capture patient perspectives which can be used in comparative effectiveness research to inform the evaluation of treatment. Thus far, PROMs have focussed on the long-term sequelae of COVID-19 rather than the acute illness and initial recovery period. Aim(s): To design a psychometrically validated COVID-19 specific PROM to be used in the acute and recovery phase of illness. Method(s): A review of existing literature, evaluation of existing PROMs, input from local experts (n=15) and in-depth qualitative concept elicitation interviews with patients (n=8) were used to create a conceptual framework which informed the generation of items included in the PROM. Cognitive interviews with patients (n=8) were then used to develop and refine the items for inclusion in the PROM and confirm the content and face validity of the draft tool. A nominal group meeting of the expert panel (n=6) was held to confirm the final items for inclusion. Result(s): The CoV-Sym PROM consists of 19 domains and 44 items which are scored using a five-point Likert scale to enable objective measurement of patients' symptomatic recovery from acute COVID-19 illness. Questions address physical, psychological and social domains. Cognitive interviews revealed acceptable content and face validity. Conclusion(s): With the involvement of both patients and experts in the development and validation process, we have created the first COVID-19 specific PROM to measure patient's symptomatic recovery from acute COVID-19 infection. It is ready for further psychometric testing to confirm reliability and responsiveness, the results of which will be presented.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Preventive intranasal flagellin protects against a multidrug resistant strain of P. aeruginosa by restoring the effect of gentamicin SARS-CoV-2 induces fibrosis-associated macrophage signatures and triggers pulmonary fibrosis Altered peripheral blood neutrophil profiles are associated with persistent symptoms post-COVID19 UPF1 is a novel factor in rhinovirus pathogenesis that is deficient in patients with severe asthma First study results of the P4O2 long COVID cohort
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1